Correlation Between Aridis Pharmaceuticals and Ibio

Can any of the company-specific risk be diversified away by investing in both Aridis Pharmaceuticals and Ibio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aridis Pharmaceuticals and Ibio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aridis Pharmaceuticals and Ibio Inc, you can compare the effects of market volatilities on Aridis Pharmaceuticals and Ibio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aridis Pharmaceuticals with a short position of Ibio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aridis Pharmaceuticals and Ibio.

Diversification Opportunities for Aridis Pharmaceuticals and Ibio

0.56

Correlation Coefficient

Aridis Pharmaceuticals  Ibio

Very weak diversification

The 3 months correlation between Aridis and Ibio is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Aridis Pharmaceuticals and Ibio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ibio Inc and Aridis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aridis Pharmaceuticals are associated (or correlated) with Ibio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ibio Inc has no effect on the direction of Aridis Pharmaceuticals i.e., Aridis Pharmaceuticals and Ibio go up and down completely randomly.

Pair Corralation between Aridis Pharmaceuticals and Ibio

If you would invest  267.00  in Ibio Inc on September 5, 2024 and sell it today you would lose (7.00) from holding Ibio Inc or give up 2.62% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	4.55%
Values	Daily Returns

Aridis Pharmaceuticals  vs.  Ibio Inc

Aridis Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aridis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Aridis Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Ibio Inc

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Ibio Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Ibio displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aridis Pharmaceuticals and Ibio

The main advantage of trading using opposite Aridis Pharmaceuticals and Ibio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aridis Pharmaceuticals position performs unexpectedly, Ibio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ibio will offset losses from the drop in Ibio's long position.

The idea behind Aridis Pharmaceuticals and Ibio Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.